Aug 2026
CCL4 as a Potential Immune-Metabolic Biomarker in Acute Myocardial Infarction via Machine Learning and Single-Cell Transcriptomics.
The findings suggest that CCL4 may serve as a potential diagnostic biomarker for AMI, and the observed immune-metabolic associations provide a basis for future mechanistic and translational studies.
Jin-Zhong Bo, Y. Xiang, Yanshuo Ni et al.
· Journal of Visualized Experi... · 0 citations